Case Study: Regeneron, Sanofi’s Dupilumab Development to approval
The U.S. Food and Drug Administration on Tuesday approved Regeneron Pharmaceuticals Inc and Sanofi SA’s drug for moderate-to-severe atopic dermatitis. Bio-molecule: Dupilumab... Read More
Amgen’s Amgevita, biosimilar of AbbVie’s Humira (adalimumab), has been approved by the European Commission
Reference Biologic – Humira (adalimumab) of AbbVie Biosimilar – Amgevita (adalimumab) of Amgen European Commission (EC) has granted marketing authorization for AMGEVITA™... Read More
EPREX of Janssen-Cilag gets French regulatory approval treating symptomatic anaemia in patients with low or intermediate-1- risk MDS
Posted on28 Mar 2017
Comments0
Janssen-Cilag International NV has announced the French health authority Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), has... Read More
European orphan drug status for NiCord to treat bone marrow transplantation
Posted on28 Mar 2017
Comments0
Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, has announced that orphan... Read More
Biogaran, a French pharmaceutical company acquired Swipha, a manufacture and marketer of pharmaceuticals in Nigeria
Acquiring Company: Biogaran, a French pharmaceutical company specialized in generic and biosimilar medicines, and a subsidiary of Servier Acquired Company: Swipha, a... Read More
New mAB approval: Avelumab for metastatic Merkel Cell Carcinoma (mMCC)
Posted on25 Mar 2017
Comments0
Biomolecule: Avelumab Brand : Bavencio Class: Monoclonal Antibodies Sub Class: Human anti-PD-L1 antibody of isotype IgG1 USFDA approval Date: 23rd March, 2017... Read More
Case Study : World’s first global “real world” trial : AstraZeneca’s diabetes drug Dapagliflozin
Posted on21 Mar 2017
TagsAstraZeneca, Dapagliflozin, What is Adaptive clinical trial?, World’s first global “real world” trial
Comments0
Molecule: Dapagliflozin Mechanism of Action: Dapagliflozin is part of a new class of drugs that act by removing excess glucose from the... Read More
Sun Pharma’s subsidiary Taro Pharmaceuticals acquired Thallion, including the rights to the drug candidate Shigamab
India largest drug maker Sun Pharma’s subsidiary Taro Pharmaceuticals has entered into an agreement with Canadian biopharmaceutical firm Bellus Health to buy... Read More
What is significance of Open Label Extension Studies in clinical trial?
Open label extension studies allow continued prescribing of unapproved drugs after a randomised trial. Open label extension studies typically follow a double... Read More
Mylan settles trastuzumab patent litigation with Genentech and Roche
Development of trastuzumab The drug was first discovered by scientists including Dr. Axel Ullrich and Dr. H. Michael Shepard at UCLA’s Jonsson Comprehensive... Read More